Publications

Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis.

Bissett, SL; Godi, A; JIT, M; Beddows, S;

2017

Vaccine, (2017).35 32 10.1016/j.vaccine.2017.06.028.

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.

Gsell, P-S; CAMACHO, A; KUCHARSKI, AJ; WATSON, CH; Bagayoko, A; Nadlaou, SD; Dean, NE; Diallo, A; Diallo, A; Honora, DA; Doumbia, M; Enwere, G; Higgs, ES; Mauget, T; Mory, D; Riveros, X; Oumar, FT; Fallah, M; Toure, A; Vicari, AS; Longini, IM; EDMUNDS, WJ; Henao-Restrepo, AM; Kieny, MP; Kéïta, S;

2017

The Lancet infectious diseases, (2017).17 12 10.1016/S1473-3099(17)30541-8.

Impact and cost-effectiveness of rotavirus vaccination in Bangladesh.

Pecenka, C; Parashar, U; Tate, JE; Khan, JA M; Groman, D; Chacko, S; Shamsuzzaman, M; CLARK, A; Atherly, D;

2017

Vaccine, (2017).35 32 10.1016/j.vaccine.2017.05.087.

Promoting influenza vaccine for children.

Edwards, A; Bedford, H; Campbell, H; Letley, L; PATERSON, P; Pebody, R; Saliba, V; Yarwood, J; Yates, J;

2017

Practice Nursing, (2017).28 10 10.12968/pnur.2017.28.10.413.

Immunization, urbanization and slums - a systematic review of factors and interventions.

CROCKER-BUQUE, T; Mindra, G; Duncan, R; MOUNIER-JACK, S;

2017

BMC public health, (2017).17 1 10.1186/s12889-017-4473-7.

Repeat pneumococcal polysaccharide vaccination does not impair functional immune responses among Indigenous Australians.

Licciardi, PV; Hoe, E; Toh, ZQ; Balloch, A; Moberley, S; Binks, P; Marimla, R; Leach, A; Skull, S; MULHOLLAND, K; Andrews, R;

2017

Clinical & translational immunology, (2017).6 10 10.1038/cti.2017.46.

What works for human papillomavirus vaccine introduction in low and middle-income countries?.

HOWARD, N; GALLAGHER, KE; MOUNIER-JACK, S; BURCHETT, HE D; Kabakama, S; LaMontagne, DS; WATSON-JONES, D;

2017

Papillomavirus research (Amsterdam, Netherlands), (2017).4, 10.1016/j.pvr.2017.06.003.

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development.

Kaufmann, SH E; DOCKRELL, HM; Drager, N; Ho, MM; McShane, H; Neyrolles, O; Ottenhoff, TH M; Patel, B; Roordink, D; Spertini, F; Stenger, S; Thole, J; Verreck, FA W; Williams, A; TBVAC2020 Consortium,;

2017

Frontiers in immunology, (2017).8 OCT 10.3389/fimmu.2017.01203.

Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya.

FLASCHE, S; OJAL, J; LE POLAIN DE WAROUX, O; OTIENDE, M; O'Brien, KL; Kiti, M; Nokes, DJ; EDMUNDS, WJ; SCOTT, JA G;

2017

BMC medicine, (2017).15 1 10.1186/s12916-017-0882-9.

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.

GALLAGHER, KE; HOWARD, N; Kabakama, S; MOUNIER-JACK, S; BURCHETT, HE D; LaMontagne, DS; WATSON-JONES, D;

2017

Papillomavirus research (Amsterdam, Netherlands), (2017).4, 10.1016/j.pvr.2017.09.001.